Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Hwa-ping Feng

Phase 1 Pharmacokinetic Study of MK-0646 (Dalotuzumab), an Anti-Insulin-Like Growth Factor-1 Receptor Monoclonal Antibody, in Combination With Cetuximab and Irinotecan in Japanese Patients With Advanced Colorectal Cancer

Cancer Chemotherapy and Pharmacology

Cancer Research

English